beta
ARDM
Aradigm Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Aradigm Corp is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases.
Market Cap: 33.9 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.aradigm.com
Shares Outstanding: 15.1 Million
Float: 11.8 Million
Dividend: 0.0 (0.0%)
Beta: 0.686654
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 1090 trading days
From: 2014-09-12 To: 2019-01-16
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|